Work

Combining HSP90 Inhibition with Standard Therapies for HER2 Positive Breast Cancer.

Year: 2009

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/0008-5472.sabcs-09-5055

Authors: Z. Qadir, Z. Qadir, J. Crown, J. Crown, M. Jensen, M. Clynes, D. Slamon, N. O'Donovan

Institutions: St. Vincent's University Hospital, Dublin City University, Novartis (Switzerland), Novartis Institutes for BioMedical Research, University of California, Los Angeles

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2034936246

Cites:

Cited by:

Related to: 10